Sep 2026
Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial.
K. Yasumura, Y. Vengrenyuk, Jia-Jia Liu et al.
· Cardiovascular Drugs and The... · 0 citations
3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Sep 2026
Sex differences in coronary plaque stabilization with evolocumab: a post hoc analysis of the YELLOW III trial.
K. Yasumura, Sarah Goldman, Y. Vengrenyuk et al.
· The International Journal of... · 0 citations
Aug 2026
Incidence, Predictors, and Clinical Impact of Early Readmission After Complex Percutaneous Coronary Intervention.
It is concluded that early rehospitalization after complex PCI is associated with worse 1-year outcomes, and clinical and procedural predictors - including sex-specific differences - should inform risk mitigation strategies to optimize post-PCI care.
F. Kalaba, Y. Garg, C. Odukwe et al.
· American Journal of Cardiolo... · 0 citations